Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 33(12): 2155-6, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2694953

RESUMO

The postantibiotic effect of oxacillin on Staphylococcus aureus ATCC 6538P was determined under different test conditions by reference (viability counting) and semiautomated (electronic counting) methods. Differences in durations of the postantibiotic effect obtained with the two counting methods were not statistically significant. The semiautomated method provided a more rapid and convenient alternative to viability counting.


Assuntos
Oxacilina/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Técnicas Bacteriológicas , Testes de Sensibilidade Microbiana
3.
J Cell Sci ; 20(3): 569-88, 1976 May.
Artigo em Inglês | MEDLINE | ID: mdl-1270531

RESUMO

The effects of inhibitors of mitosis, energy metabolism and protein synthesis on clot retraction were investigated. The results show that (1) Incubation of colchicine (0-01-0-1 mM) with platelet-rich plasma (PRP) inhibits the subsequent retraction of clots derived from diluted PRP. (2) Inhibition of clot retraction by high concentrations of colchicine (up to 40 mM) can be overcome by increasing the platelet concentration in the system. (3) Incubation of clots in colchicine or 80% D2O solutions inhibits their retraction. Exposure of partially retracted clots to these agents is without effect. (4) Hydrostatic pressure retards clot retraction. (5) Incubation of PRP with either 2-deoxy-D-glucose or antimycin alone does not affect clot retraction, but a combination of these agents is inhibitory. (6) Clot retraction is not inhibited by puromycin or cycloheximide. (7) Platelets in retracting clots have constricted regions containing microfilaments and pseudopods containing microtubules. Fibrin strands are progressively condensed around the constricted regions as retraction advances. (8) The development of platelet constriction, platelet pseudopods and the intracellular microfilaments are delayed in colchicinized clots, corresponding to the retardation of retraction. Following the initial delay of retraction colchicinized clots, like controls, show condensation of fibrin strands adjacent to these constricted areas of platelets containing microfilaments. The formation of pseudopods is impaired and no microtubules are found in platelets in the presence of colchicine. The above results suggest that the thrombin-induced platelet contraction during clot retraction is a coordinated movement, which, under optimal conditions involves both microtubules and microfilaments. The contraction of microfilaments produces the constriction of platelets and brings about clot retraction by reducing the angle between fibrin strands. Platelet microtubules are related to the development of pseudopods and play a supplementary role in facilitating microfilament-mediated cellular constriction. The similarities between platelet contraction and cellular motility in mitosis is discussed.


Assuntos
Plaquetas/fisiologia , Retração do Coágulo , Microtúbulos/fisiologia , Mitose , Antimicina A/farmacologia , Plaquetas/ultraestrutura , Movimento Celular , Colchicina/farmacologia , Cicloeximida/farmacologia , Desoxiglucose/farmacologia , Deutério/farmacologia , Relação Dose-Resposta a Droga , Humanos , Pressão Hidrostática , Microtúbulos/ultraestrutura , Pseudópodes/ultraestrutura , Puromicina/farmacologia , Temperatura
5.
Med Clin North Am ; 59(2): 339-46, 1975 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1117769

RESUMO

More precise definition of the cytokinetic parameters of human tumor growth will clearly help both in predicting the outcome of disease in individual patients and in planning the dosage schedules of single chemotherapeutic agents and combinations of agents to achieve optimal results.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias/tratamento farmacológico , Doença Aguda , Adenocarcinoma/metabolismo , Animais , Antineoplásicos/farmacologia , Divisão Celular/efeitos dos fármacos , Neoplasias do Colo/metabolismo , Técnicas de Cultura , Citarabina/farmacologia , DNA/biossíntese , Humanos , Cinética , Leucemia/patologia , Meiose/efeitos dos fármacos , Melanoma/patologia , Mitose/efeitos dos fármacos , Neoplasias/patologia , Neoplasias Experimentais/metabolismo , Neoplasias Experimentais/patologia , Ratos , Timidina/metabolismo , Timidina/farmacologia , Trítio , Vimblastina/farmacologia
11.
Bull Parenter Drug Assoc ; 23(5): 208-14, 1969.
Artigo em Inglês | MEDLINE | ID: mdl-5344402
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA